Filing Details
- Accession Number:
- 0001127602-22-028317
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-28 16:32:38
- Reporting Period:
- 2022-12-27
- Accepted Time:
- 2022-12-28 16:32:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1531048 | Inari Medical Inc. | NARI | Surgical & Medical Instruments & Apparatus (3841) | 452902923 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1806426 | Thomas Tu | C/O Inari Medical, Inc. 6001 Oak Canyon Irvine CA 92618 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-27 | 10,000 | $0.46 | 96,451 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-27 | 6,529 | $62.75 | 89,922 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-27 | 1,871 | $63.88 | 88,051 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-27 | 1,400 | $64.66 | 86,651 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-27 | 200 | $65.67 | 86,451 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2022-12-27 | 10,000 | $0.00 | 10,000 | $0.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
159,584 | 2029-04-23 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
- This transaction was executed in multiple trades at prices ranging from $62.39 to $63.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $63.39 to $64.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $64.43 to $64.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The option vested with respect to 25% of the underlying shares on April 23, 2020, and vests with respect to the remaining shares in 36 equal monthly installments thereafter.